Pharmacists are reminded of the potential for serious interactions to occur between miconazole and warfarin resulting in an enhanced anticoagulant effect of warfarin. Following reports of serious bleeding in patients taking miconazole and warfarin, the Medicines and Healthcare products Regulatory Agency (MHRA) is reviewing data to ascertain whether additional measures are necessary to reduce these risks.
Pharmacists are reminded of the following:
Further information can be found in the MHRA Drug Safety Update Volume 9, Issue 11, June 2016.
For further information on this or any other query, members can contact the NPA Pharmacy Services team on 01727 891 800 or email firstname.lastname@example.org.